ASPEN PHARMACARE UK LIMITED
Get an alert when ASPEN PHARMACARE UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2027-01-20 (in 8mo)
Last made up 2026-01-06
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£15M
-32.4% vs 2024
Employees
—
Average over period
Profit before tax
£2M
-30.3% vs 2024
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-06-30
| Metric | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Turnover | £29,663,000 | £29,584,000 | |
| Operating profit | £2,904,000 | £1,774,000 | |
| Profit before tax | £3,268,000 | £2,278,000 | |
| Net profit | £2,439,000 | £1,641,000 | |
| Cash | £1,115,000 | — | |
| Total assets less current liabilities | £22,789,000 | £15,433,000 | |
| Net assets | £22,748,000 | £15,389,000 | |
| Equity | £22,748,000 | £15,389,000 | |
| Average employees | — | — | |
| Wages | £1,659,000 | £1,525,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating margin | 9.8% | 6.0% | |
| Net margin | 8.2% | 5.5% | |
| Return on capital employed | 12.7% | 11.5% | |
| Gearing (liabilities / total assets) | 28.8% | 34.5% | |
| Current ratio | 3.25x | 2.62x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company generated a net profit of £1 641 000 (2024: £2 439 000) and has a net asset position of £15 389 000 (2024: £22 748 000). The current assets of the Company exceed its current liabilities by £13 044 000 (2024: £20 620 000). Although the Company had negative cash flows of £1 115 000 for the year ended 30 June 2025 (2024: negative cash flows of £198 000), the Company has the availability of unutilized funding facilities. The directors have also considered the Company's budgets and cash flow forecasts for the period to 31 December 2026. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the annual report and financial statements.”
Group structure
- ASPEN PHARMACARE UK LIMITED · parent
- Aspen Pharma Ireland Limited
- Aspen Global Incorporated
- Aspen Pharmacare Holdings Limited
Significant events
- “The directors are not aware of any material event which occurred after the reporting date and up to the date of this report.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FRIGGIERI, Daniel Vella | Director | 2025-12-31 | Jun 1977 | Maltese |
| SCOTT, Nicholas Peter | Director | 2018-06-12 | Nov 1968 | British |
| VAN DER LINDE, Carnie | Director | 2025-12-31 | Mar 1969 | South African |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOTHA, Chris Mynhard | Director | 2020-02-01 | 2025-12-31 |
| DAVIES, Derek | Director | 2018-06-12 | 2020-02-01 |
| DENCHER, Dennis | Director | 2018-06-12 | 2019-08-15 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 29 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-03 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-03 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-03 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-19 | CH01 | officers | Change person director company with change date | |
| 2026-01-19 | CH01 | officers | Change person director company with change date | |
| 2025-12-03 | AA | accounts | Accounts with accounts type full | |
| 2025-01-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-26 | AA | accounts | Accounts with accounts type full | |
| 2024-08-16 | CH01 | officers | Change person director company with change date | |
| 2024-08-16 | CH01 | officers | Change person director company with change date | |
| 2024-04-15 | AA | accounts | Accounts with accounts type full | |
| 2024-01-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-18 | AA | accounts | Accounts with accounts type full | |
| 2023-01-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-08 | AA | accounts | Accounts with accounts type full | |
| 2022-07-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-03-12 | AA | accounts | Accounts with accounts type dormant |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
-
Turnover
-0.3%
£29,663,000 £29,584,000
-
Cash
—
Not reported
-
Net assets
-32.4%
£22,748,000 £15,389,000
-
Employees
—
Not reported
-
Operating profit
-38.9%
£2,904,000 £1,774,000
-
Profit before tax
-30.3%
£3,268,000 £2,278,000
-
Wages
-8.1%
£1,659,000 £1,525,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers